Author

Annie Ferng

Ionis Pharmaceuticals (United States)

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Anastasia DiamantopoulouiD· 1 shared Bin XuiD· 1 shared Curt MazuriD· 1 shared Holly B. KordasiewicziD· 1 shared Joseph A. GogosiD· 1 shared Khakima Khalizova· 1 shared Martin LackingeriD· 1 shared Pratibha ThakuriD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperNeuroscience

Anastasia DiamantopoulouORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

An antisense oligonucleotide-based strategy to ameliorate cognitive dysfunction in the 22q11.2 Deletion Syndrome

Pratibha Thakur, Martin Lackinger, Anastasia Diamantopoulou, Sneha B. Rao, Yijing Chen, Khakima Khalizova, Annie Ferng, Curt Mazur, Holly B. Kordasiewicz, Robert J. Shprintzen, Sander Markx, Bin Xu, Joseph A. Gogos

This study shows that reducing EMC10 levels in 22q11.2 deletion syndrome models improves cognitive function and sustains benefits for over two months.

eLife · Apr 17, 2025Peer-reviewedNeuroscience